Brief: Redcare Pharmacy NV Q2 Total Sales Growth Up At EUR 421 Mln
06/07/2023 05:50
July 6 (Reuters) - REDCARE PHARMACY NV RDC.DE :
* VERY SUCCESSFUL QUARTER FOR REDCARE PHARMACY N.V. WITH A
FURTHER
ACCELERATION IN SALES GROWTH.
* Q2 SALES 421.0 MILLION EUR
* FOR PERIOD MID-MAY TO END OF 2023, MEDISERVICE SALES OF
AROUND
EUR 300 MILLION ARE EXPECTED AT THIS MOMENT
* TOTAL SALES GROWTH 47% TO EUR 421M IN Q2.
* Q2 YEAR TO DATE SALES EUR 793M, A GROWTH OF 34%
* EXCLUDING SALES OF MEDISERVICE AG (TRANSACTION WITH
GALENICA AG
COMPLETED MID-MAY), SALES GROWTH WAS 26% TO EUR 361M IN Q2 AND
24% TO EUR 733M YEAR TO DATE, DRIVEN BY STRONG ORGANIC GROWTH IN
ALL OF REDCARE PHARMACY'S SEVEN COUNTRIES.
* NON-RX SALES GROWTH'S STRONG TREND CONTINUED AND
ACCELERATED;
27% IN Q2 (TO EUR 324M) AND 25% YEAR TO DATE (TO EUR 661M).
* MILESTONE OF SURPASSING 10M-MARK IN ACTIVE CUSTOMER BASE
REACHED; UP 0.4M IN Q2, 0.8M YEAR TO DATE AND 1.5M YEAR OVER
YEAR TO 10.1M
* Q2 CONTINUED HIGH CUSTOMER SATISFACTION (NPS ABOVE 70)
Source text for Eikon: ID:nEQb0qw00a
Further company coverage: RDC.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))